Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Dopamine Agonists
1.2.3 Levodopa
1.2.4 Glutamate Antagonist
1.2.5 Apomorphine
1.2.6 COMT Inhibitors Anticholinergics
1.2.7 MAO-B Inhibitors
1.2.8 Other Drugs
1.3 Market by Application
1.3.1 Global Parkinson's Disease Treatments Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Healthcare Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Treatments Market Perspective (2018-2034)
2.2 Parkinson's Disease Treatments Growth Trends by Region
2.2.1 Global Parkinson's Disease Treatments Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Parkinson's Disease Treatments Historic Market Size by Region (2018-2023)
2.2.3 Parkinson's Disease Treatments Forecasted Market Size by Region (2024-2034)
2.3 Parkinson's Disease Treatments Market Dynamics
2.3.1 Parkinson's Disease Treatments Industry Trends
2.3.2 Parkinson's Disease Treatments Market Drivers
2.3.3 Parkinson's Disease Treatments Market Challenges
2.3.4 Parkinson's Disease Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Treatments Players by Revenue
3.1.1 Global Top Parkinson's Disease Treatments Players by Revenue (2018-2023)
3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2018-2023)
3.2 Global Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Treatments Revenue
3.4 Global Parkinson's Disease Treatments Market Concentration Ratio
3.4.1 Global Parkinson's Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Treatments Revenue in 2024
3.5 Parkinson's Disease Treatments Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Treatments Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Treatments Breakdown Data by Type
4.1 Global Parkinson's Disease Treatments Historic Market Size by Type (2018-2023)
4.2 Global Parkinson's Disease Treatments Forecasted Market Size by Type (2024-2034)
5 Parkinson's Disease Treatments Breakdown Data by Application
5.1 Global Parkinson's Disease Treatments Historic Market Size by Application (2018-2023)
5.2 Global Parkinson's Disease Treatments Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Parkinson's Disease Treatments Market Size (2018-2034)
6.2 North America Parkinson's Disease Treatments Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Parkinson's Disease Treatments Market Size by Country (2018-2023)
6.4 North America Parkinson's Disease Treatments Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson's Disease Treatments Market Size (2018-2034)
7.2 Europe Parkinson's Disease Treatments Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Parkinson's Disease Treatments Market Size by Country (2018-2023)
7.4 Europe Parkinson's Disease Treatments Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Treatments Market Size (2018-2034)
8.2 Asia-Pacific Parkinson's Disease Treatments Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2018-2023)
8.4 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Treatments Market Size (2018-2034)
9.2 Latin America Parkinson's Disease Treatments Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Parkinson's Disease Treatments Market Size by Country (2018-2023)
9.4 Latin America Parkinson's Disease Treatments Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Treatments Market Size (2018-2034)
10.2 Middle East & Africa Parkinson's Disease Treatments Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2018-2023)
10.4 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Parkinson's Disease Treatments Introduction
11.1.4 GSK Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Parkinson's Disease Treatments Introduction
11.2.4 Merck Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Parkinson's Disease Treatments Introduction
11.3.4 Novartis Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva Parkinson's Disease Treatments Introduction
11.4.4 Teva Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.4.5 Teva Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Impax
11.6.1 Impax Company Detail
11.6.2 Impax Business Overview
11.6.3 Impax Parkinson's Disease Treatments Introduction
11.6.4 Impax Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.6.5 Impax Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Detail
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson's Disease Treatments Introduction
11.7.4 Abbvie Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.7.5 Abbvie Recent Development
11.8 Bausch Health
11.8.1 Bausch Health Company Detail
11.8.2 Bausch Health Business Overview
11.8.3 Bausch Health Parkinson's Disease Treatments Introduction
11.8.4 Bausch Health Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.8.5 Bausch Health Recent Development
11.9 Lundbeck
11.9.1 Lundbeck Company Detail
11.9.2 Lundbeck Business Overview
11.9.3 Lundbeck Parkinson's Disease Treatments Introduction
11.9.4 Lundbeck Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.9.5 Lundbeck Recent Development
11.10 Sun Pharma
11.10.1 Sun Pharma Company Detail
11.10.2 Sun Pharma Business Overview
11.10.3 Sun Pharma Parkinson's Disease Treatments Introduction
11.10.4 Sun Pharma Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.10.5 Sun Pharma Recent Development
11.11 Wockhardt
11.11.1 Wockhardt Company Detail
11.11.2 Wockhardt Business Overview
11.11.3 Wockhardt Parkinson's Disease Treatments Introduction
11.11.4 Wockhardt Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.11.5 Wockhardt Recent Development
11.12 Acadia
11.12.1 Acadia Company Detail
11.12.2 Acadia Business Overview
11.12.3 Acadia Parkinson's Disease Treatments Introduction
11.12.4 Acadia Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.12.5 Acadia Recent Development
11.13 UCB
11.13.1 UCB Company Detail
11.13.2 UCB Business Overview
11.13.3 UCB Parkinson's Disease Treatments Introduction
11.13.4 UCB Revenue in Parkinson's Disease Treatments Business (2018-2023)
11.13.5 UCB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Parkinson's Disease Treatments Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Dopamine Agonists
Table 3. Key Players of Levodopa
Table 4. Key Players of Glutamate Antagonist
Table 5. Key Players of Apomorphine
Table 6. Key Players of COMT Inhibitors Anticholinergics
Table 7. Key Players of MAO-B Inhibitors
Table 8. Key Players of Other Drugs
Table 9. Global Parkinson's Disease Treatments Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 10. Global Parkinson's Disease Treatments Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 11. Global Parkinson's Disease Treatments Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Parkinson's Disease Treatments Market Share by Region (2018-2023)
Table 13. Global Parkinson's Disease Treatments Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 14. Global Parkinson's Disease Treatments Market Share by Region (2024-2034)
Table 15. Parkinson's Disease Treatments Market Trends
Table 16. Parkinson's Disease Treatments Market Drivers
Table 17. Parkinson's Disease Treatments Market Challenges
Table 18. Parkinson's Disease Treatments Market Restraints
Table 19. Global Parkinson's Disease Treatments Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Parkinson's Disease Treatments Market Share by Players (2018-2023)
Table 21. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Treatments as of 2024)
Table 22. Ranking of Global Top Parkinson's Disease Treatments Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Parkinson's Disease Treatments Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Parkinson's Disease Treatments Product Solution and Service
Table 26. Date of Enter into Parkinson's Disease Treatments Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Parkinson's Disease Treatments Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Parkinson's Disease Treatments Revenue Market Share by Type (2018-2023)
Table 30. Global Parkinson's Disease Treatments Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 31. Global Parkinson's Disease Treatments Revenue Market Share by Type (2024-2034)
Table 32. Global Parkinson's Disease Treatments Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Parkinson's Disease Treatments Revenue Market Share by Application (2018-2023)
Table 34. Global Parkinson's Disease Treatments Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 35. Global Parkinson's Disease Treatments Revenue Market Share by Application (2024-2034)
Table 36. North America Parkinson's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. North America Parkinson's Disease Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Parkinson's Disease Treatments Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Parkinson's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 40. Europe Parkinson's Disease Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Parkinson's Disease Treatments Market Size by Country (2024-2034) & (US$ Million)
Table 42. Asia-Pacific Parkinson's Disease Treatments Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 43. Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2024-2034) & (US$ Million)
Table 45. Latin America Parkinson's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Latin America Parkinson's Disease Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Parkinson's Disease Treatments Market Size by Country (2024-2034) & (US$ Million)
Table 48. Middle East & Africa Parkinson's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2024-2034) & (US$ Million)
Table 51. GSK Company Detail
Table 52. GSK Business Overview
Table 53. GSK Parkinson's Disease Treatments Product
Table 54. GSK Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Merck Company Detail
Table 57. Merck Business Overview
Table 58. Merck Parkinson's Disease Treatments Product
Table 59. Merck Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Parkinson's Disease Treatments Product
Table 64. Novartis Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Teva Company Detail
Table 67. Teva Business Overview
Table 68. Teva Parkinson's Disease Treatments Product
Table 69. Teva Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 70. Teva Recent Development
Table 71. Boehringer Ingelheim Company Detail
Table 72. Boehringer Ingelheim Business Overview
Table 73. Boehringer Ingelheim Parkinson's Disease Treatments Product
Table 74. Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 75. Boehringer Ingelheim Recent Development
Table 76. Impax Company Detail
Table 77. Impax Business Overview
Table 78. Impax Parkinson's Disease Treatments Product
Table 79. Impax Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 80. Impax Recent Development
Table 81. Abbvie Company Detail
Table 82. Abbvie Business Overview
Table 83. Abbvie Parkinson's Disease Treatments Product
Table 84. Abbvie Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 85. Abbvie Recent Development
Table 86. Bausch Health Company Detail
Table 87. Bausch Health Business Overview
Table 88. Bausch Health Parkinson's Disease Treatments Product
Table 89. Bausch Health Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 90. Bausch Health Recent Development
Table 91. Lundbeck Company Detail
Table 92. Lundbeck Business Overview
Table 93. Lundbeck Parkinson's Disease Treatments Product
Table 94. Lundbeck Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 95. Lundbeck Recent Development
Table 96. Sun Pharma Company Detail
Table 97. Sun Pharma Business Overview
Table 98. Sun Pharma Parkinson's Disease Treatments Product
Table 99. Sun Pharma Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 100. Sun Pharma Recent Development
Table 101. Wockhardt Company Detail
Table 102. Wockhardt Business Overview
Table 103. Wockhardt Parkinson's Disease Treatments Product
Table 104. Wockhardt Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 105. Wockhardt Recent Development
Table 106. Acadia Company Detail
Table 107. Acadia Business Overview
Table 108. Acadia Parkinson's Disease Treatments Product
Table 109. Acadia Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 110. Acadia Recent Development
Table 111. UCB Company Detail
Table 112. UCB Business Overview
Table 113. UCB Parkinson's Disease Treatments Product
Table 114. UCB Revenue in Parkinson's Disease Treatments Business (2018-2023) & (US$ Million)
Table 115. UCB Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Treatments Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Parkinson's Disease Treatments Market Share by Type: 2024 VS 2034
Figure 3. Dopamine Agonists Features
Figure 4. Levodopa Features
Figure 5. Glutamate Antagonist Features
Figure 6. Apomorphine Features
Figure 7. COMT Inhibitors Anticholinergics Features
Figure 8. MAO-B Inhibitors Features
Figure 9. Other Drugs Features
Figure 10. Global Parkinson's Disease Treatments Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 11. Global Parkinson's Disease Treatments Market Share by Application: 2024 VS 2034
Figure 12. Hospitals Case Studies
Figure 13. Healthcare Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Parkinson's Disease Treatments Report Years Considered
Figure 16. Global Parkinson's Disease Treatments Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 17. Global Parkinson's Disease Treatments Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Parkinson's Disease Treatments Market Share by Region: 2024 VS 2034
Figure 19. Global Parkinson's Disease Treatments Market Share by Players in 2024
Figure 20. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Treatments as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Parkinson's Disease Treatments Revenue in 2024
Figure 22. North America Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. North America Parkinson's Disease Treatments Market Share by Country (2018-2034)
Figure 24. United States Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Canada Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Europe Parkinson's Disease Treatments Market Share by Country (2018-2034)
Figure 28. Germany Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Asia-Pacific Parkinson's Disease Treatments Market Share by Region (2018-2034)
Figure 36. China Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Japan Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. South Korea Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Southeast Asia Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. India Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Australia Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Latin America Parkinson's Disease Treatments Market Share by Country (2018-2034)
Figure 44. Mexico Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Brazil Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Parkinson's Disease Treatments Market Share by Country (2018-2034)
Figure 48. Turkey Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Saudi Arabia Parkinson's Disease Treatments Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. GSK Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 53. Teva Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 55. Impax Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 56. Abbvie Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 57. Bausch Health Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 58. Lundbeck Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 59. Sun Pharma Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 60. Wockhardt Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 61. Acadia Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 62. UCB Revenue Growth Rate in Parkinson's Disease Treatments Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed